The parathyroid glands in chronic renal failure: a study of their growth and other properties made on the basis of findings in patients with hypercalcemia
- PMID: 2677197
The parathyroid glands in chronic renal failure: a study of their growth and other properties made on the basis of findings in patients with hypercalcemia
Abstract
We investigated the growth of hyperplastic parathyroid glands removed at operation from 16 patients with chronic renal failure complicated by hypercalcemia, by incubating fresh tissue with tritiated thymidine. In each gland the proportion of cells synthesizing DNA was determined directly by counting labeled nuclei after autoradiography and indirectly from incorporation of label into DNA, and the mean diameter of chief cell nuclei was measured. Both DNA synthesis and mean nuclear diameter were positively correlated with plasma calcium level. Assuming the mean duration of S phase to be 12 hours, the birthrate of new cells (mean +/- SD) was 18.5% +/- 23.6% per year, significantly (p less than 0.05) greater than the 11.5% +/- 7.4% per year found in 63 parathyroid adenomas previously studied. On the basis of estimated disease duration, the minimum birthrate needed to grow glands of the observed weight was 23.4% +/- 16.5% per year. The similarity between observed and needed birthrates indicates that the glands were growing almost as fast as when renal failure began, and that parathyroid growth was no longer regulated in accordance with normal plasma calcium homeostasis. To account for this, we propose that the disordered growth is a consequence of an increase in secretory set point, which in turn is a consequence of calcitriol deficiency. Because the effectiveness of parathyroid hormone is impaired in renal failure, a large increase in total hormone secretion is needed to raise the plasma calcium level to the new set point, and the necessary increase in gland size can be achieved only by a sustained increase in the rate of cell division.
Similar articles
-
Effect of calcium and magnesium on deoxyribonucleic acid synthesis in rat parathyroid glands in vitro.Lab Invest. 1975 Jul;33(1):72-9. Lab Invest. 1975. PMID: 1170463
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
In vivo studies of parathyroid gland function in secondary hyperparathyroidism.Adv Nephrol Necker Hosp. 1996;25:289-302. Adv Nephrol Necker Hosp. 1996. PMID: 8717632 Review.
-
Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation.World J Surg. 1988 Aug;12(4):431-8. doi: 10.1007/BF01655411. World J Surg. 1988. PMID: 3420928 No abstract available.
-
[The role of calcium, calcitriol and their receptors in parathyroid regulation].Nefrologia. 2009;29(2):103-8. doi: 10.3265/Nefrologia.2009.29.2.5154.en.full. Nefrologia. 2009. PMID: 19396314 Review. Spanish.
Cited by
-
Chronic kidney disease mineral and bone disorder in children.Pediatr Nephrol. 2008 Feb;23(2):195-207. doi: 10.1007/s00467-007-0671-3. Epub 2007 Nov 28. Pediatr Nephrol. 2008. PMID: 18046581 Free PMC article. Review.
-
Secondary hyperparathyroidism: pathophysiology, histopathology, and medical and surgical management.Surg Today. 1997;27(9):787-92. doi: 10.1007/BF02385267. Surg Today. 1997. PMID: 9306599 Review.
-
Phosphate administration increases both size and number of parathyroid cells in adult rats.Calcif Tissue Int. 1996 Jan;58(1):40-4. doi: 10.1007/BF02509544. Calcif Tissue Int. 1996. PMID: 8825237
-
Parathyroid gland function in secondary hyperparathyroidism.Pediatr Nephrol. 1996 Jun;10(3):359-63. doi: 10.1007/BF00866785. Pediatr Nephrol. 1996. PMID: 8792406 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical